Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q1 2024 ▲▼ | Q2 2024 ▲▼ | Change ▲▼ | Q1 2024 ▲▼ | Q2 2024 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Pharvaris N.V. COM | 4,038,842 | 4,293,854 | +255,012 | $93.34M | $80.72M | 54.23% | -$12.61M |
| Kura Oncology, Inc.(KURA) | 1,849,947 | 1,849,947 | 0 | $39.46M | $38.09M | 25.59% | -$1.37M |
| Syndax Pharmaceuticals, Inc.(SNDX) | 875,000 | 875,000 | 0 | $20.82M | $17.96M | 12.07% | -$2.86M |
| Lyell Immunopharma, Inc.(LYEL) | 8,325,000 | 8,325,000 | 0 | $18.56M | $12.07M | 8.11% | -$6.49M |
| Kinnate Biopharma Inc. | 9,671,643 | 0 | -9,671,643 | $25.73M | $0 | — | -$25.73M |